Not all forms of HRT raise MI risk

Some forms of HRT may not increase MI risk, a Danish study of almost 700,000 women suggests.

This is the largest study to examine the effects of HRT since the Women's Health Initiative study was stopped in 2002 after linking HRT to an increased risk of breast cancer and thromboembolism.

The observational study followed 698,098 healthy women aged 51 to 69 from 1995 to 2001. It found that overall HRT did not increase the risk of MI, but that women aged 51-54 who took HRT during the period of the study had a 24 per cent higher risk of suffering an MI.

This risk also depended on the type of HRT used. A continuous combination of oestrogen and progesterone was associated with a 35 per cent increased risk of MI, but oestrogen followed by a combination of oestrogen and progesterone was associated with a reduced risk.

Meanwhile oestrogen cut MI risk by 38 per cent via a skin patch, and by 44 per cent if applied via a vaginal gel.

tom.moberly@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Most children could be removed from shielded patient list, deputy CMO suggests

Most children could be removed from shielded patient list, deputy CMO suggests

Most children could be removed from the shielded patient list in a future wave of...

GPs can provide some care for shielded patients in clinical settings, NHS England confirms

GPs can provide some care for shielded patients in clinical settings, NHS England confirms

GPs can provide care to shielded patients in 'infection-controlled clinical settings'...

How digital assistants can help patients manage their health and wellbeing

How digital assistants can help patients manage their health and wellbeing

A project in Staffordshire has shown how practices can make use of digital technology...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

Fair death-in-service deal for locums vital before second COVID-19 wave, warns BMA

Fair death-in-service deal for locums vital before second COVID-19 wave, warns BMA

The government must do ‘the right thing’ and secure adequate death-in-service benefits...

GP workload fears over antibody testing rollout for 'no clinical benefit'

GP workload fears over antibody testing rollout for 'no clinical benefit'

GP practices are being contacted by patients asking for antibody tests as the government...